Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa
The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the burden and impact of immune reconstitution disease (IRD) associated with tuberculosis (TB) among patients initiating antiretroviral treatment (ART) in sub-Saharan Africa. DESIGN: Retrospective analysis of a study cohort enrolled over 3 years within a community-based ART service in South Africa. METHODS: Patients receiving treatment for TB at the time ART was initiated (n = 160) were studied. Cases of TB-associated IRD during the first 4 months of ART were ascertained. RESULTS: The median baseline CD4 cell count was 68 cells/microl [interquartile range (IQR), 29-133 cells/microl) and ART was initiated after a median of 105 days (IQR, 61-164 days) from TB diagnosis. Although IRD was diagnosed in just 12% (n = 19) of patients overall, IRD developed in 32% (n = 12) of those who started ART within 2 months of TB diagnosis. Pulmonary involvement was observed in 84% (n = 16) and intra-abdominal manifestations were also common (37%). Overall, 4% (n = 7) of the cohort required secondary level health-care for IRD and two (1%) patients died. In multivariate analysis, risk of IRD was strongly associated with early ART initiation and low baseline CD4 cell count. Of patients with CD4 counts < 50 cells/microl, the proportions who developed IRD following initiation of ART within 0-30, 31-60, 61-90, 91-120 and > 120 days of TB diagnosis were 100%, 33%, 14%, 7% and 0%, respectively. CONCLUSIONS: The risk of TB-associated IRD in this setting is very high for those with low baseline CD4 cell counts initiating ART early in the course of antituberculosis treatment. However, most cases were self-limiting; overall secondary health-care utilization and mortality risk from IRD were low.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, HIV-positive patients with apparent sole pulmonary tuberculosis may develop peripheral or central lymphadenitis as the manifestation of IRIS [58].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [58]
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Growing Burden of Tuberculosis: Global Trends and Interactions With the HIV Epidemic
Corbett, E. L., Watt, C. J., Walker, N., Maher, D., Williams, B. G., Raviglione, M. C., & Dye, C. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.9.1009 · Cited by 2,553 · cited 1×
“A majority of the global burden of HIV-associated tuberculosis (TB) lies in sub-Saharan Africa [1] and rates in southern Africa have reached almost unprecedented”
BackgroundTuberculosis in Patients with Human Immunodeficiency Virus Infection
Havlir, D. V., & Barnes, P. F. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400507 · Cited by 1,461 · cited 1×
“Moreover, the risks associated with TB-IRD are important variables in the debate over the optimal time for ART initiation in patients with TB [7,8,10].”
BackgroundShelburne, S. A., Visnegarwala, F., Darcourt, J., Graviss, E. A., Giordano, T. P., White, A. C., & Hamill, R. J. (2005) · AIDS · doi:10.1097/01.aids.0000161769.06158.8a · Cited by 632 · cited 3×
“In common with most previous studies [9,19,20,22,23], diagnoses of IRD were made retrospectively but were nevertheless based on systematically collected prospective data.”
BackgroundParadoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608 · cited 2×
“patients attending referral hospitals [9,20,21,23].”
ResultLawn, S. D., Bekker, L.-G., & Miller, R. F. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70140-7 · Cited by 545 · cited 7×
“Moreover, the risks associated with TB-IRD are important variables in the debate over the optimal time for ART initiation in patients with TB [7,8,10].”
BackgroundMethodInfluentialSelf-citationParadoxical reactions during tuberculosis treatment in patients with and without HIV co-infection
Breen, R. A. M. (2004) · Thorax · doi:10.1136/thx.2003.019224 · Cited by 367 · cited 4×
“In common with most previous studies [9,19,20,22,23], diagnoses of IRD were made retrospectively but were nevertheless based on systematically collected prospective data.”
BackgroundInfluentialLawn, S. D., Myer, L., Bekker, L.-G., & Wood, R. (2006) · AIDS · doi:10.1097/01.aids.0000238406.93249.cd · Cited by 363
Self-citationLawn, S. D., Myer, L., Orrell, C., Bekker, L.-G., & Wood, R. (2005) · AIDS · doi:10.1097/01.aids.0000194802.89540.e1 · Cited by 359 · cited 3×
“reported that cryptococcal IRD is a far more common cause of death in this service [12,15].”
BackgroundMethodResultSelf-citationTreatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S. G., Ives, N. J., Matthews, G., Fox, E. F., Navaratne, L., Fisher, M., Taylor, G. P., Miller, R., Taylor, C. B., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354
Cited by
Items 201–300 of 346
Tan, D. H. S., & Walmsley, S. L. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.010 · Cited by 14
Immune Reconstitution Inflammatory Syndrome in HIV-Infected Immigrants
Pérez-Rueda, M., Hernández-Cabrera, M., Francés, A., Ángel-Moreno, A., Pisos-Álamo, E., Jaén‐Sánchez, N., Carranza‐Rodriguez, C., & Pérez-Arellano, J.-L. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0773 · Cited by 15
O’Shea, M. K., & Wilson, D. R. (2013) · Journal of the Royal Army Medical Corps · doi:10.1136/jramc-2013-000115 · Cited by 15
Short and Long-Term Incidence of Tuberculosis and CD4-Cell Count Dynamic on HAART in Senegal
François, E. J., Diouf, A., Beaudrap, P. D., Koivogui, A., Fatou, N.-G. N., Ibrahima, N., Écochard, R., Salif, S. P., & Delaporte, É. (2009) · The Open AIDS Journal · doi:10.2174/1874613600903010063 · Cited by 12
“During the early period on HAART, we hypothesis that there was a mixture of mechanisms among the 25 ARTassociated TB cases: i) some clinical cases left undiagnosed at HAART initiation due to the lack of sensitive diagnosis tests with a persistent immunodeficiency and ii) subclinical latent cases at HAART initiation wi…”
BackgroundImmune reconstitution inflammatory syndrome
Lawn, S. D., & Wood, R. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70280-2 · Cited by 13
Self-citationNarendran, G., Jyotheeswaran, K., Senguttuvan, T., Vinhaes, C. L., Santhanakrishnan, R. K., Manoharan, T., Selvaraj, A., Padmapriyadarsini, C., Menon, P. A., Bhavani, P. K., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.097 · Cited by 14
“Paradoxical tuberculosis (TB)-immune reconstitution inflammatory syndrome (TB-IRIS) is the apparent clinical or radiological deterioration seen in pre-existing lesions or emergence of new TB lesions after anti-retroviral therapy (ART) initiation among human immunodeficiency virus (HIV)-TB coinfected patients, despite…”
BackgroundLimmahakhun, S., Chaiwarith, R., Nuntachit, N., Sirisanthana, T., & Supparatpinyo, K. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2012.011291 · Cited by 11
Friedland, G. (2009) · Clinical Infectious Diseases · doi:10.1086/596765 · Cited by 11
Perceptions and Attitudes of Health Workers towards Patients Co-infected with HIV and Tuberculosis
Phetlhu, D. R., & Watson, M. J. (2011) · Journal of Social Sciences · doi:10.1080/09718923.2011.11892951 · Cited by 14
Starke, J. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00136-7 · Cited by 11
Antinori, A., Ammassari, A., Torti, C., Marconi, P., Andreoni, M., Angarano, G., Bonora, S., Castagna, A., Cauda, R., Clerici, M., et al. (2009) · Infection · doi:10.1007/s15010-008-8134-8 · Cited by 10
“Studies have shown that the risk of IRIS is associated with baseline CD4 cell count as well as early initiation of cART and that severe, lifethreatening manifestations are uncommon [48, 59 , 60].”
BackgroundStellbrink, H. J., Baldus, S. E., Behrens, G. M. N., Bogner, J. R., Harrer, T., Hoffmann, C., van Lunzen, J., Münch, J., Rácz, P., Scheller, C., et al. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-1-1 · Cited by 9
Tan, H. Y., Yong, Y. K., Lim, S. H., Ponnampalavanar, S. S. L., Omar, S. F. S., Pang, Y. K., Kamarulzaman, A., Price, P., Crowe, S. M., & French, M. A. (2014) · Sexual Health · doi:10.1071/sh14093 · Cited by 12
Chilton, D., Edwards, S., Pellegrino, P., & Miller, R. F. (2008) · Thorax · doi:10.1136/thx.2008.104232 · Cited by 9
Pulmonary Complications of Human Immunodeficiency Virus Infection
Crothers, K. A., Morris, A., & Huang, L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-4710-0.00080-8 · Cited by 10
Clinical Features and Management of HIV/AIDS
Wood, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-7020-5101-2.00011-x · Cited by 8
Self-citationDas, R., Sarkar, S., & Besra, M. (2013) · Indian Journal of Sexually Transmitted Diseases and AIDS · doi:10.4103/0253-7184.120552 · Cited by 8
Update on immune reconstitution inflammatory syndrome: Progress and unanswered questions
Kelley, C. F., & Armstrong, W. S. (2009) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0070-y · Cited by 9
“The degree of CD4 + T-cell count improvement after 6 months of ART in cryptococcal meningitis [15] and early initiation of ART after TB diagnosis [ 16 ] also increased risk for IRIS.”
BackgroundLawn, S. D., Edwards, D., & Wood, R. (2007) · Future HIV Therapy · doi:10.2217/17469600.1.4.387 · Cited by 9
“This has been observed to occur in 8–43% of TB patients after starting ART [17,45–52].”
BackgroundResultSelf-citationThe Korean Society for AIDS (2012) · Infection and Chemotherapy · doi:10.3947/ic.2012.44.3.93 · Cited by 8
Antiretroviral Therapy for Human Immunodeficiency Virus Infection
Tsibris, A. M. N., & Hirsch, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00128-4 · Cited by 11
Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection
Masur, H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00129-6 · Cited by 13
Coping with TB immune reconstitution inflammatory syndrome
Worodria, W. O., Conesa-Botella, A., Kisembo, H. N., McAdam, K. P. W. J., & Colebunders, R. (2009) · Expert Review of Respiratory Medicine · doi:10.1586/ers.09.8 · Cited by 7
Starke, J. R. (2010) · Handbook of clinical neurology · doi:10.1016/s0072-9752(09)96011-0 · Cited by 5
“However, some adults with pulmonary tuberculosis and HIV infection have experienced tuberculoma as a paradoxical reaction to institution of antituberculosis and anti-HIV chemotherapy, the so-called immune reconstitution inflammatory syndrome (IRIS) (Crump et al., 1998; Lawn et al., 2005, 2007).”
BackgroundCholedochal cyst in pregnancy.
Koh, K. S., Bickle, I., Mathew, V. V., & Chong, V. H. (2016) · Europe PMC (PubMed Central) · Cited by 6
Drug-Resistant Tuberculosis in Sub-Saharan Africa
Hafkin, J., Gammino, V. M., & Amon, J. J. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-009-0074-7 · Cited by 7
“IRIS frequently complicates the management of coinfected individuals [ 37 ] and may be associated with the treatment of DRTB in HIV-coinfected patients [38].”
BackgroundSyndromes de reconstitution immune
Breton, G. (2009) · Réanimation · doi:10.1016/j.reaurg.2009.03.004 · Cited by 7
Jaganmohan, D., Chakkalakkoombil, S. V., Beena, A. A., & Nagarajan, K. (2016) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.4103/0971-3026.195782 · Cited by 6
“Similarly, in a study conducted by Marais et al.,[16] 47% of TB meningitis patients developed TB meningitis‑IRIS.”
BackgroundInfluentialThe White and the Three-Letter Plague: Integration of TB and HIV Care in Sub-Saharan Africa
Wallrauch, C., Bärnighausen, T., Heller, T., Houlihan, C. F., & Newell, M. (2008) · Future HIV Therapy · doi:10.2217/17469600.2.5.437 · Cited by 7
“population in KwaZulu-Natal (2008), Submitted], the high prevalence of TB disease among HIV-positive patients complicated ART roll-out because treatment of both diseases needs careful planning to avoid potentially lethal immune reconstitution inflammatory syndrome (IRIS) [17] and there is the potential for multiple dr…”
BackgroundDirix, V., Schepers, K., Loembé, M. M., Worodria, W. O., Colebunders, R., Singh, M., Locht, C., Kestens, L., Mascart, F., & TB-IRIS study group (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000980 · Cited by 6
Tuberculosis in HIV-infected patients: prevalence, clinical manifestations, treatment efficiency
Abdullaev, R. Y., Комиссарова, О. Г., & Герасимов, Л. Н. (2018) · Vrach · doi:10.29296/25877305-2018-11-02 · Cited by 5
Chang, M. H., Guo, Y., Acbo, A., Bao, H., McSweeney, T. D., Vo, C., & Nori, P. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.04.002 · Cited by 5
Elenga, N. (2013) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000235 · Cited by 5
“Indeed, many recent studies have reported an increased incidence of TB-associated IRIS [19-30].”
BackgroundInfluentialHIV/AIDS Disease Burden Complex in South Africa
Abayomi, E. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384703-4.00125-8 · Cited by 5
Chiang, S. S., & Starke, J. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00134-8 · Cited by 5
Antiretroviral therapy for HIV-associated tuberculosis
Avihingsanon, A., Hemachandra, A., & van der Lugt, J. (2009) · doi:10.5372/947 · Cited by 7
Uppuluri, R., & Shah, I. (2014) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957413516384 · Cited by 5
Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection
Masur, H. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00131-4 · Cited by 7
Bell, L., Peyper, J. M., Garnett, S., Tadokera, R., Wilkinson, R. J., Meintjes, G., & Blackburn, J. M. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.02.008 · Cited by 6
“The incidence of IRIS varies from b10% to N50% (Meintjes and Lynen, 2008; Narendran et al., 2013; French, 2007; Breton et al., 2004; Shelburne et al., 2005; Michailidis et al., 2005; Manosuthi et al., 2006; Lawn et al., 2007; Burman et al., 2007; Namale et al., 2015; Breen et al., 2004; Olalla et al., 2002) and a meta…”
BackgroundInfluentialHIV and tuberculosis--a "cursed duo" in the HAART era.
Londhey, V. (2009) · PubMed · Cited by 8
Mashiri, C. E., Batidzirai, J. M., Chifurira, R., & Chinhamu, K. (2024) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed9070154 · Cited by 4
“HIV patients, particularly those with low CD4 counts, must receive appropriate and timely tuberculosis screening, preventive therapy, and access to ART.”
BackgroundWu, Y., Yang, Y., Wei, H., Jia, L., Jiang, T., Tian, Y., Guo, C., & Zhang, Y. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26977 · Cited by 4
Arshad, I., Gandhi, M., Gossai, M., & Feinstein, A. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.939210 · Cited by 4
Li, L., Li, J., Chai, C., Liu, T., Li, P., Qu, M., & Zhao, H. (2021) · PubMed Central · Cited by 8
La co-infection VIH – Tuberculose
Harmouche, H., & Ammouri, W. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.09.009 · Cited by 5
Immune reconstitution infl ammatory syndrome
Müller, M. C. M. (2010) · Cited by 4
Pulmonary Complications of HIV Infection
Morris, A., Crothers, K. A., & Huang, L. (2016) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0036-1579582 · Cited by 4
Syndrome inflammatoire de reconstitution immune
Breton, G. (2011) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32064-3 · Cited by 6
Schmaltz, C. A. S., Santoro‐Lopes, G., & Rolla, V. C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31819001d5 · Cited by 4
Controlling Inflammation: A Superior Way to Control TB
Gupta, N., Agrawal, B., & Kumar, R. K. (2016) · Immunotherapy · doi:10.2217/imt-2016-0070 · Cited by 5
Ferrand, H., Joly, V., & Yazdanpanah, Y. (2013) · Réanimation · doi:10.1007/s13546-013-0700-4 · Cited by 4
“Les patients présentant une tuberculose pulmonaire peuvent développer une atteinte extrapulmonaire initialement non diagnostiquée [22].”
BackgroundApproaches to clinical trials of new anti-TB drugs
Bark, C. M., Furin, J. J., & Johnson, J. L. (2012) · Clinical Investigation · doi:10.4155/cli.12.22 · Cited by 3
Good visual outcome of tuberculous chorioretinitis after ART initiation in a HIV-infected patient
Schaftenaar, E., Meenken, C., Baarsma, G. S., Verjans, G. M. G. M., & Peters, R. P. H. (2014) · International Ophthalmology · doi:10.1007/s10792-014-9997-6 · Cited by 3
Research Priorities for HIV/M. tuberculosis Co-Infection
Álvarez, M. A., Arbeláez, P. E. J., Bastos, F. I., Berkhout, B., Bhattacharya, B., Bocharov, G. A., Черешнев, В. А., Cuchí, P., Däumer, M., Demikhova, O. V., et al. (2011) · The Open Infectious Diseases Journal · doi:10.2174/1874279301005010014 · Cited by 3
Laparra, A., Lerolle, N., Gérin, M., Chéret, A., Castro, N. D., Gallien, S., Pourcher, V., Lanternier, F., Bourgarit, A., & Goujard, C. (2021) · AIDS · doi:10.1097/qad.0000000000002823 · Cited by 3
TB/AIDS Coinfection: An Integrated Clinical and Research Response
Goldfeld, A. E., & Corbett, E. L. (2009) · Wiley eBooks · doi:10.1002/9783527627905.ch9 · Cited by 3
Oliver, B. G., & Price, P. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.16 · Cited by 3
Tuberculosis in Immunocompromised Hosts
Christianakis, S., Banerjee, J., Kim, J. S., & Jones, B. E. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7098-5_8 · Cited by 3
“IRIS occurs in approximately 10–30% of patients with HIV-related tuberculosis [1, 2].”
BackgroundDisorders of immune reconstitution in patients with HIV infection
French, M. A., & Meintjes, G. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00092-7 · Cited by 3
Acute and chronic bacterial infections and sarcoidosis
Deigendesch, N., & Stenzel, W. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00016-x · Cited by 4
Human Immunodeficiency Virus Infection and the Acquired Immunodeficiency Syndrome
Dhanireddy, S., & Harrington, R. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4060-3.00015-6 · Cited by 4
Future of HIV/AIDS Care in Low- and Middle- Income Countries
Hoffmann, C. J., Mills, L. A., & Gallant, J. E. (2008) · Springer eBooks · doi:10.1007/978-0-387-72711-0_3 · Cited by 3
“High rates of endemic illness, OIs, and the low CD4 count at ART initiation in many ART rollout programs has led to high rates of IRIS in low and middle-income countries (Lawn et al., 2007), and some of the excess early mortality seen in the first 3–6 months after ART initiation is likely due to IRIS.”
BackgroundStarke, J. R. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50112-6 · Cited by 3
INTEGRATION OF TUBERCULOSIS (TB) AND HIV
Ansa, G. A. (2011) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 3
Immune reconstitution inflammatory syndrome in children
Rabie, H., Meyers, T., & Cotton, M. F. (2009) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v10i4.263 · Cited by 3
Teshome, G., & Tsegaw, A. (2023) · HIV & AIDS Review · doi:10.5114/hivar.2023.131494 · Cited by 2
Integrating the care of HIV and TB in developing countries
Wood, R. (2007) · Therapy · doi:10.2217/14750708.4.6.787 · Cited by 2
Self-citationSyndrome inflammatoire de reconstitution immune (IRIS) associé à la tuberculose
Breton, G. (2012) · Journal des Anti-infectieux · doi:10.1016/j.antinf.2012.09.001 · Cited by 3
Oliver, B. G., Haddow, L. J., Agarwal, U., Kumar, M., Easterbrook, P., Moosa, M. S., Singh, S., & Price, P. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828e6182 · Cited by 2
Lortholary, O., Roussillon, C., Boucherie, C., Padoin, C., Chaix, M., Breton, G., Rami, A., Véziris, N., Patey, O., Caumes, É., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv384 · Cited by 2
Wake, R. M., Poulikakos, P., Groth, J., Harrison, T. S., & Macallan, D. C. (2013) · International Journal of STD & AIDS · doi:10.1177/0956462412472431 · Cited by 2
HIV and Immune Reconstitution Inflammatory Syndrome (HIV-IRIS)
Mustapha, S., Chakib, A., & Marhoum El Filali, K. (2018) · Cited by 2
The Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome (TB-IRIS)
Sereti, I., Bisson, G. P., & Meintjes, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-29108-2_6 · Cited by 2
Paradoxical Reactions and the Immune Reconstitution Infl ammatory Syndrome
Church, P., & Judson, M. A. (2021) · Wiley eBooks · doi:10.1128/9781555817138.ch34 · Cited by 2
Mugusi, S. F. (2013) · Figshare · Cited by 2
Treatment of HIV‐related tuberculosis—unresolved issues
Burman, W. J. (2008) · Respirology · doi:10.1111/j.1440-1843.2008.01339.x · Cited by 2
Aghamohammadi, A., Abolhassani, H., Caracseghi, F., & Soler‐Palacín, P. (2012) · Springer eBooks · doi:10.1007/978-3-642-31785-9_1 · Cited by 1
Shyamal, S. S., Ray, R., Bhowmik, R., Manaithiya, A., & Aspatwar, A. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-026-00795-3 · Cited by 1
“The clinical management of HIV-associated TB includes effective anti-TB treat - ment, concurrent antiretroviral therapy (ART), prevention of HIV-related comorbidities, management of drug toxicity, and prevention/treatment of immune reconstitution inflam - matory syndrome (IRIS) (Lawn et al. 2007 , World Health et al.…”
A patient with multiple IRIS : case study
Asselman, V., & Meinjes, G. (2007) · Southern African Journal of HIV Medicine · Cited by 3
53-jähriger Patient mit Fieber und Husten
Orasch, C., & Battegay, M. (2009) · Der Internist · doi:10.1007/s00108-009-2340-z · Cited by 1
“Auch wenn ein IRIS auftritt, sollte die ART weitergeführt werden, weil ein IRIS üblicherweise nicht lebensbedrohlich ist [10].”
BackgroundL’Her, P., André, M., & L'Her, P. (2008) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(08)56034-7 · Cited by 1
Meyer‐Olson, D., Ernst, D., & Stoll, M. (2012) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-011-0858-7 · Cited by 1
Immune Reconstitution Disorders in Patients with HIV Infection
French, M. A., & Meintjes, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-7020-6285-8.00095-2 · Cited by 1
Clinical Complications of Antiretroviral Therapy in HIV/TB Patients in Referral Hospital, China
Li, Z., Du, S., Xiao, Z., & Jiang, X. (2017) · Future Virology · doi:10.2217/fvl-2016-0102 · Cited by 1
Tariq, Z. A. (2018) · Medbiotech Journal · doi:10.22034/mbt.2018.61528 · Cited by 1
Retnaningsih, R., Udji, M. A., & Anandika, D. D. (2021) · Bali Medical Journal · doi:10.15562/bmj.v10i1.2231 · Cited by 1
Dowdy, D. W., Chaisson, R. E., & Churchyard, G. (2015) · doi:10.1093/med/9780199661756.003.0214 · Cited by 1
Hartigan-O’Connor, D. J., & Brander, C. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780197679098.003.0006 · Cited by 1
HIV / TB : when is it safe to start HAART? : debate
Wood, R. (2008) · Southern African Journal of HIV Medicine · Cited by 1
Self-citationEvolución clínica e inmunovirológica de individuos VIH positivos con tuberculosis en Cuba
Corcho, A. R., de Paz, V. C., Jidy, M. D., Ávila, J. P., & Jiménez, Y. B. (2007) · Revista del Instituto Nacional de Enfermedades Respiratorias · Cited by 1
Schiffer, J. T., & Sterling, T. R. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181398d73 · Cited by 1
Hoskins, S. (2014) · UCL Discovery (University College London) · Cited by 1
Harries, A. D., Zachariah, R., Chimzizi, R. B., Salaniponi, F. M. L., & Lawn, S. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9780511751660.019
Self-citationImmune Reconstitution Inflammatory Syndrome
Soentjens, P. H. P., Meintjes, G., French, M. A., & Colebunders, R. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch18
Tuberculosis case finding in HIV-positive adults receiving care at health centres in Ethiopia
Balcha, T. T. (2015) · Lund University Publications (Lund University) · doi:10.13140/rg.2.1.2384.0163
Kabue, J. P. (2009) · SUNScholar (Stellenbosch University)
Management of Late Presentation in Hiv: What the Data Tell Us
Mallon, P. W. G., & Powderly, W. G. (2009) · HIV Therapy · doi:10.2217/hiv.09.32
Siegel, M., & Benator, D. (2008) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e31818dlad3
The immune reconstitution inflammatory syndrome and antiretroviral therapy
Lorent, N., Conesa-Botella, A., & Colebunders, R. (2010) · British Journal of Hospital Medicine · doi:10.12968/hmed.2010.71.12.691 · Cited by 1
Metadata
- Authors
- Lawn, S. D., Myer, L., Bekker, L.-G., & Wood, R.
- Affiliations
- University of Cape Town (ZA)
- Corresponding author
- Lawn, Stephen D
- Venue
- AIDS
- Published
- 2007-01-30
- Volume
- 21
- Issue
- 3
- Pages
- 335-341
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2020198464
- Cited by
- 343
- References
- 27
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 16 · 2013: 31 · 2012: 25
- FWCI
- 51.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Wellcome Trust (074641)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- National Institute of Allergy and Infectious Diseases (1U19 AI53217-01, AI 058736-01A1, U19AI053217, R01AI058736)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- tuberculosis, antiretroviral therapy, CD4 count, early ART initiation, risk factors, pulmonary tuberculosis, South Africa
- MeSH terms
- Adult, Antitubercular Agents, Developing Countries, Epidemiologic Methods, Female, Humans, Immune System Diseases, Inflammation, Male, South Africa, Tuberculosis, HIV Infections, AIDS-Related Opportunistic Infections, CD4 Lymphocyte Count, Anti-HIV Agents, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.